MEDLIVE (02192) announced that on January 5, 2026, a total of 700,000 ordinary shares were issued to two directors of the Company who exercised their share options pursuant to the pre-IPO share option scheme adopted on March 29, 2021.

Additionally, on the same date, 230,000 ordinary shares were issued to one employee of the Company who exercised share options under the same pre-IPO share option scheme.